| Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing CHL Kürten, A Kulkarni, AR Cillo, PM Santos, AK Roble, S Onkar, ... Nature communications 12 (1), 7338, 2021 | 177 | 2021 |
| Improving head and neck cancer therapies by immunomodulation of the tumour microenvironment AT Ruffin, H Li, L Vujanovic, DP Zandberg, RL Ferris, TC Bruno Nature Reviews Cancer 23 (3), 173-188, 2023 | 160 | 2023 |
| Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial RL Ferris, WC Spanos, R Leidner, A Gonçalves, UM Martens, C Kyi, ... Journal for immunotherapy of cancer 9 (6), e002568, 2021 | 159 | 2021 |
| Adenovirus MART-1–engineered autologous dendritic cell vaccine for metastatic melanoma LH Butterfield, B Comin-Anduix, L Vujanovic, Y Lee, VB Dissette, JQ Yang, ... Journal of immunotherapy 31 (3), 294-309, 2008 | 148 | 2008 |
| Virally infected and matured human dendritic cells activate natural killer cells via cooperative activity of plasma membrane-bound TNF and IL-15 L Vujanovic, DE Szymkowski, S Alber, SC Watkins, NL Vujanovic, ... Blood, The Journal of the American Society of Hematology 116 (4), 575-583, 2010 | 93 | 2010 |
| Expression of Tim-3 drives phenotypic and functional changes in Treg cells in secondary lymphoid organs and the tumor microenvironment H Banerjee, H Nieves-Rosado, A Kulkarni, B Murter, KV McGrath, ... Cell reports 36 (11), 2021 | 79 | 2021 |
| Dendritic cell‐based vaccines positively impact natural killer and regulatory T cells in hepatocellular carcinoma patients SM Bray, L Vujanovic, LH Butterfield Journal of Immunology Research 2011 (1), 249281, 2011 | 64 | 2011 |
| Melanoma cancer vaccines and anti‐tumor T cell responses L Vujanovic, LH Butterfield Journal of cellular biochemistry 102 (2), 301-310, 2007 | 59 | 2007 |
| CD56dim CD16− Natural Killer Cell Profiling in Melanoma Patients Receiving a Cancer Vaccine and Interferon-α L Vujanovic, C Chuckran, Y Lin, F Ding, CA Sander, PM Santos, J Lohr, ... Frontiers in immunology 10, 14, 2019 | 54 | 2019 |
| IL-12p70 and IL-18 gene-modified dendritic cells loaded with tumor antigen-derived peptides or recombinant protein effectively stimulate specific Type-1 CD4+ T-cell responses … L Vujanovic, E Ranieri, A Gambotto, WC Olson, JM Kirkwood, WJ Storkus Cancer gene therapy 13 (8), 798-805, 2006 | 52 | 2006 |
| Multiple antigen-engineered DC vaccines with or without IFNα to promote antitumor immunity in melanoma LH Butterfield, L Vujanovic, PM Santos, DM Maurer, A Gambotto, J Lohr, ... Journal for immunotherapy of cancer 7, 1-15, 2019 | 45 | 2019 |
| Adenovirus-engineered human dendritic cells induce natural killer cell chemotaxis via CXCL8/IL-8 and CXCL10/IP-10 L Vujanovic, W Ballard, SH Thorne, NL Vujanovic, LH Butterfield Oncoimmunology 1 (4), 448-457, 2012 | 42 | 2012 |
| A Mycoplasma Peptide Elicits Heteroclitic CD4+ T Cell Responses against Tumor Antigen MAGE-A6 L Vujanovic, M Mandic, WC Olson, JM Kirkwood, WJ Storkus Clinical cancer research 13 (22), 6796-6806, 2007 | 42 | 2007 |
| Inhibition of soluble tumor necrosis factor prevents chemically induced carcinogenesis in mice A Sobo-Vujanovic, L Vujanovic, AB DeLeo, F Concha-Benavente, ... Cancer immunology research 4 (5), 441-451, 2016 | 37 | 2016 |
| Regulation of antigen presentation machinery in human dendritic cells by recombinant adenovirus L Vujanovic, TL Whiteside, DM Potter, J Chu, S Ferrone, LH Butterfield Cancer Immunology, Immunotherapy 58, 121-133, 2009 | 37 | 2009 |
| Human dendritic cells adenovirally-engineered to express three defined tumor antigens promote broad adaptive and innate immunity LAT Blalock, J Landsberg, M Messmer, J Shi, AD Pardee, R Haskell, ... Oncoimmunology 1 (3), 287-357, 2012 | 35 | 2012 |
| Melanoma vaccines: clinical status and immune endpoints DM Maurer, LH Butterfield, L Vujanovic Melanoma research 29 (2), 109-118, 2019 | 33 | 2019 |
| Tumor-derived α-fetoprotein directly drives human natural killer–cell activation and subsequent cell death L Vujanovic, EC Stahl, AD Pardee, DA Geller, A Tsung, SC Watkins, ... Cancer immunology research 5 (6), 493-502, 2017 | 32 | 2017 |
| ADAM10 sheddase activity is a potential lung-cancer biomarker T Yoneyama, M Gorry, A Sobo-Vujanovic, Y Lin, L Vujanovic, ... Journal of Cancer 9 (14), 2559, 2018 | 31 | 2018 |
| Route of antigen delivery impacts the immunostimulatory activity of dendritic cell-based vaccines for hepatocellular carcinoma AD Pardee, H Yano, AM Weinstein, AAK Ponce, AD Ethridge, ... Journal for ImmunoTherapy of Cancer 3, 1-16, 2015 | 29 | 2015 |
